In an opinion piece in the Guardian’s “Comment is Free” blog, Dean Baker, co-director of the Center for Economic and Policy Research, discusses potential policies contained within the “Trans-Pacific Partnership Agreement (TPP), a pact that the United States is negotiating with Australia, Canada, Japan and eight other countries in the Pacific region.” However, “[a]t this point, it’s not really possible to discuss the merits of the TPP since the governments are keeping the proposed text a secret from the public,” he says. Noting “[a] few items that have been leaked give us some insight as to the direction of this pact,” he discusses how the “pharmaceutical industry is … likely to be a big gainer” from the TPP if the pact includes “stronger and longer patent protection and also increased use of ‘data exclusivity.'”
Private Sector Involvement
In a post in the Guardian’s “Sustainable Business” blog, Lisa Herman, managing director of the global health practice area at consulting firm FSG, and Mike Stamp, a senior consultant with FSG, discuss “a new guide for companies on how to participate in global action on women and children’s health” recently launched at the London Family Planning Summit. “The guide, co-authored by social impact consultants FSG and sponsored by the Innovation Working Group in support of the global Every Woman, Every Child effort, sets out concrete opportunities for companies from many different industries to contribute to improving women and children’s health,” they write.
Peace Corps, PEPFAR, Global Health Service Corps Launch Public-Private Partnership To Place Medical Professionals Overseas
The Peace Corps, PEPFAR and the Global Health Service Corps on Tuesday will announce a public-private partnership program to place U.S. health workers overseas to help address medical professional shortages, CQ HealthBeat reports (Bristol, 3/12). “The Global Health Service Partnership (GHSP) will address health professional shortages by investing in capacity and building support for existing medical and nursing education programs in less-developed countries,” a joint press release (.pdf) states, adding, “The new program is expected to begin in Tanzania, Malawi and Uganda in July 2013.”
In this “Health Affairs Blog” post, Sachin Jain, a physician and former HHS adviser, explores the use of the term “strategy” in global health, writing “the term remains variably used and ill-defined.” He “offer[s] a definition enumerated for use by for-profit firms: Strategy is the unique set of activities and operating structures that an organization puts in place to deliver value to its customers,” and offers explanation about each segment of the definition. He concludes, “Strategy requires that organizations puzzle through different sets of ‘conflicting virtues’ — funders, activities, customers — and establish a priority order among them. None of these decisions are without their challenges; deciding to clearly define and grapple with them, however, will be an important step towards greater organizational effectiveness and results” (3/12).
IRIN examines ColaLife — a pilot project set to start in Zambia in September 2012 that will ship single-dose anti-diarrhea kits (ADKs) in crates of Coca-Cola bottles in an effort to increase the coverage of oral rehydration salts (ORS) for the treatment of diarrhea in children in the developing world. “Three-quarters of [diarrhea-related] deaths could be prevented with a simple course of [ORS] combined with zinc tablets, at a cost of just $0.50 per patient,” but, “despite being heavily promoted by the World Health Organization since the 1970s, fewer than 40 percent of child diarrhea cases in developing countries are treated with ORS,” the news service writes.
Inadequate Government TB Program, Lax Drug Sale Regulations Contributing To MDR-TB Cases In India, Health Groups Say
“India’s inadequate government-run tuberculosis [TB] treatment programs and a lack of regulation of the sale of drugs that fight the disease are responsible for the [increasing] number of drug-resistant cases that are difficult to treat,” health advocacy organizations said in India last week, the Associated Press/Huffington Post reports. “India adds an estimated 99,000 cases of drug-resistant TB every year, but only a tiny fraction of those infected receive the proper” six- to nine-month antibiotic regimen, according to the AP. In India, government-run TB treatment programs only provide drugs to patients on alternate days, increasing the likelihood of missed doses, and patients increasingly are turning to private physicians who are unaware of how to treat the disease, Medecins Sans Frontieres in India and other health groups said, the news agency reports. “The Indian government had no response Friday to requests for comment on the activists’ allegations,” the AP writes (Naqvi, 3/23).
The Millennium Challenge Corporation (MCC) provides a fact sheet (.pdf) detailing its efforts to improve access to water, sanitation and hygiene (WASH) in the developing world. According to the fact sheet, the MCC and its partner countries “have prioritized WASH sector development,” and “MCC has invested $793 million in WASH-related projects in nine partner countries” (3/19).
VOA News reports on a March 20 panel meeting in Washington, D.C., that highlighted the contributions of corporations and non-governmental organizations (NGOs) to the Global Fund to Fight AIDS, Tuberculosis and Malaria. Chevron, which has “invested $30 million for the three-year period between 2008 and 2011 and has pledged another $25 million through 2013,” was recognized at the meeting as “the first Global Fund Corporate Champion,” according to VOA (DeCapua, 3/23).
The Center for Global Health Policy’s “Science Speaks” blog reports on a panel discussion hosted on Wednesday by the Consensus for Development Reform and the Modernizing Foreign Assistance Network in Washington, D.C. “Foreign assistance experts discuss[ed] the George W. Bush administration’s legacy on global development, focusing on lessons learned and applying them to the next decade and beyond,” and a central theme was the engagement of the private sector, the blog writes. Panelists highlighted the Millennium Challenge Corporation and PEPFAR, according to the blog (Mazzotta, 3/29).
Ethiopia’s new HIV/AIDS workplace policy, instituted in January by the government in cooperation with the country’s main employees’ and employers’ associations, “is expected to protect job seekers from mandatory HIV tests, while facilitating voluntary counseling and testing and defending the right of employees living with HIV to medical leave or job re-allocation,” PlusNews reports. The policy “provides guidelines for the establishment of an AIDS fund to help employees cope with living with the virus” and “stipulates that employers will make the necessary investments to ensure universal precautions in workplaces to protect employees from HIV infection, and … put in place a post-exposure prophylaxis system for their workforce,” the news service writes. Tadele Yimer, president of the Ethiopian Employers Federation, said, “What we hope [the new policy] will do is bring about an agreed consent and uniform approach among employers to fight HIV/AIDS nationally,” according to PlusNews (3/26).